Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients

Institute of Cancer Research, United Kingdom · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
pembrolizumabtargeted-therapytriple-negative-breast-cancer
triple negative breast cancer, breast cancer early stage, circulating tumour dna, pembrolizumab, targeted therapy, randomised clinical trial, phase ii, mutation screening, intermediate endpoint, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 805598
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.